Thursday, September 28, 2006

McGill researchers say reanalysis confirms antacids raise risk of C. difficile

If I was a researcher, I'd really like to set up a study to determine the difference in effectiveness between H2 blockers and proton pump inhibitors. This article is an arguement to avoid the PPI's when possible.

From CBC News:
Widely prescribed antacid drugs appear to be linked to a higher rate of C. difficile cases in people who have acquired the nasty bacterium outside of hospitals, a team of Montreal researchers reported Monday in the Canadian Medical Association Journal.

Using data collected on the patients of family doctors in Britain, the researchers showed that non-hospitalized people who took drugs known as proton pump inhibitors were three and a half times more likely to develop Clostridium difficile than people who didn't take the popular drugs. ...more

No comments: